Published in Med Clin (Barc) on October 02, 1999
[Primary prevention of cardiovascular events by acetylsalicylic acid in patients with hypertension in Spain]. Med Clin (Barc) (2000) 0.75
The origin of symptoms on the brain-gut axis in functional dyspepsia. Gastroenterology (1991) 2.45
Irritable bowel syndrome prevalence varies enormously depending on the employed diagnostic criteria: comparison of Rome II versus previous criteria in a general population. Scand J Gastroenterol (2001) 2.12
European Society of Hypertension practice guidelines for home blood pressure monitoring. J Hum Hypertens (2010) 2.06
[Drug combinations: an alternative in the treatment of arterial hypertension]. Med Clin (Barc) (1995) 2.04
Previous antimalarial therapy in patients diagnosed with lupus nephritis: influence on outcomes and survival. Lupus (2008) 2.00
Control of hypertension in coronary heart disease. Int J Cardiol (2008) 1.93
Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines. J Hypertens (2003) 1.93
Secretagogue-specific effects of interleukin-1 on gastric acid secretion. Am J Physiol (1991) 1.45
Low frequency of upper gastrointestinal complications in a cohort of high-risk patients taking low-dose aspirin or NSAIDS and omeprazole. Scand J Gastroenterol (2003) 1.44
Effect of salt intake on endothelium-derived factors in a group of patients with essential hypertension. Clin Sci (Lond) (2001) 1.44
Normal values in ambulatory oesophageal pH monitoring at two levels in Spain. Rev Esp Enferm Dig (2010) 1.43
[Relationship between cardiovascular risk profile and anti-hypertensive drug use. GEDEC (Spanish group of cardiovascular studies]. Med Clin (Barc) (2000) 1.42
[Tuberculous meningitis with atypical presentation in a patient with human immunodeficiency virus infection]. Med Clin (Barc) (1992) 1.39
[Relationship between severity of essential arterial hypertension and the prevalence hyperuricemia]. Med Clin (Barc) (2001) 1.38
Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: a prospective study. Hypertension (1998) 1.32
Molecular basis of salt sensitivity in human hypertension. Evaluation of renin-angiotensin-aldosterone system gene polymorphisms. Hypertension (2001) 1.21
Endothelial dysfunction in salt-sensitive essential hypertension. Hypertension (2001) 1.19
Uric acid as a cardiovascular risk factor in arterial hypertension. J Hypertens (1999) 1.12
Renin-angiotensin system genetic polymorphisms and salt sensitivity in essential hypertension. Hypertension (2000) 1.07
ESH-ESC guidelines for the management of hypertension. Herz (2006) 1.05
Does Helicobacter pylori infection increase gastric sensitivity in functional dyspepsia? Gut (1995) 1.00
Salivary anti-Ro60 and anti-Ro52 antibody profiles to diagnose Sjogren's Syndrome. J Dent Res (2011) 0.98
Oral calcium supplementation reduces intraplatelet free calcium concentration and insulin resistance in essential hypertensive patients. Hypertension (1997) 0.97
Cardiovascular risk factors in primary Sjögren's syndrome: a case-control study in 624 patients. Lupus (2010) 0.95
Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study. Diabetologia (2009) 0.95
Long-term beneficial effects of angiotensin-converting enzyme inhibition in patients with nephrotic proteinuria. Am J Kidney Dis (1992) 0.95
Change over time of bowel habit in irritable bowel syndrome: a prospective, observational, 1-year follow-up study (RITMO study). Aliment Pharmacol Ther (2007) 0.94
Hormonal, renal, and metabolic alterations during hypertension induced by chronic inhibition of NO in rats. Am J Physiol (1994) 0.94
Effects of body-weight loss and captopril treatment on proteinuria associated with obesity. Nephron (1995) 0.93
Fluid, ionic and hormonal changes induced by high salt intake in salt-sensitive and salt-resistant hypertensive patients. Clin Sci (Lond) (1996) 0.93
Mechanisms underlying the protective effects of interleukin 1 in experimental nonsteroidal anti-inflammatory drug gastropathy. Gastroenterology (1992) 0.93
Predictive factors of irritable bowel syndrome improvement: 1-year prospective evaluation in 400 patients. Aliment Pharmacol Ther (2006) 0.93
Microalbuminuria in essential hypertension. Kidney Int Suppl (1998) 0.92
Increased insulin resistance in salt sensitive essential hypertension. J Hum Hypertens (2001) 0.92
Serum beta 2-microglobulin as a marker of activity in systemic lupus erythematosus. Scand J Rheumatol (1986) 0.90
[Acute abdomen due to hemoperitoneum as the first manifestation of a liver tumor. Report of four cases (author's transl)]. Med Clin (Barc) (1979) 0.90
Renal vein thrombosis, nephrotic syndrome, and focal lupus glomerulonephritis. Br Med J (1978) 0.90
Nephrotic proteinuria without hypoalbuminemia: clinical characteristics and response to angiotensin-converting enzyme inhibition. Am J Kidney Dis (1991) 0.89
Effects of hCGRP I and II on gastric blood flow and acid secretion in anesthetized rabbits. Am J Physiol (1989) 0.89
Pressure natriuresis in nitric oxide-deficient hypertensive rats: effect of antihypertensive treatments. J Am Soc Nephrol (1999) 0.88
Influence of a low sodium diet on the renal response to amino acid infusions in humans. Kidney Int (1987) 0.88
Placebo in functional dyspepsia: symptomatic, gastrointestinal motor, and gastric sensorial responses. Am J Gastroenterol (1999) 0.88
Squamous cell carcinoma of the renal pelvis associated with hypercalcemia and the presence of parathyroid hormone-like substances in the tumor. J Urol (1985) 0.88
Lack of correlation between two methods for the assessment of salt sensitivity in essential hypertension. J Hum Hypertens (2002) 0.87
Acute worsening of renal function during episodes of macroscopic hematuria in IgA nephropathy. Kidney Int (1985) 0.87
Occult lead intoxication as a cause of hypertension and renal failure. Nephrol Dial Transplant (1996) 0.86
Partial deficit of hypoxanthine guanine phosphoribosyl transferase presenting as acute renal failure. Nephron (1987) 0.86
Influence of diabetes and type of hypertension on response to antihypertensive treatment. Hypertension (2000) 0.85
Cardiovascular risk profile and risk stratification of the hypertensive population attended by general practitioners and specialists in Spain. The CONTROLRISK study. J Hum Hypertens (2007) 0.85
Assessment of salt sensitivity in essential hypertension by 24-h ambulatory blood pressure monitoring. Am J Hypertens (1995) 0.84
Losartan reduces phenylephrine constrictor response in aortic rings from spontaneously hypertensive rats. Role of nitric oxide and angiotensin II type 2 receptors. Hypertension (1996) 0.84
Atorvastatin prevents glomerulosclerosis and renal endothelial dysfunction in hypercholesterolaemic rabbits. Nephrol Dial Transplant (2001) 0.84
AT(1) receptor antagonism reduces endothelial dysfunction and intimal thickening in atherosclerotic rabbits. Hypertension (1999) 0.83
Participation of nitric oxide in the regulation of renal function: possible role in the genesis of arterial hypertension. J Hypertens (1994) 0.83
Antihypertensive treatment efficacy in type II diabetes mellitus. Dissociation between casual and 24-hour ambulatory blood pressure. Spanish Multicenter Study Group. Hypertension (1995) 0.83
Effect of alcohol abstinence on blood pressure: assessment by 24-hour ambulatory blood pressure monitoring. Hypertension (1999) 0.82
Intragastric behavior and absorption kinetics of a normal and "floating" modified-release capsule of isradipine under fasted and fed conditions. J Pharm Sci (1988) 0.82
Renal and vascular consequences of the chronic nitric oxide synthase inhibition. Effects of antihypertensive drugs. Am J Hypertens (1996) 0.82
Pulmonary alveolar microlithiasis with an unusual radiological pattern. Br J Dis Chest (1982) 0.82
Effect of atorvastatin on endothelium-dependent constrictor factors in dyslipidemic rabbits. Gen Pharmacol (2000) 0.82
Salt sensitivity: concept and pathogenesis. Diabetes Res Clin Pract (1998) 0.82
Interpreting treatment-induced blood pressure reductions measured by ambulatory blood pressure monitoring. J Hum Hypertens (2013) 0.81
Lack of association between ACE gene polymorphism and left ventricular hypertrophy in essential hypertension. J Hum Hypertens (2000) 0.81
Exogenous cGMP prevents decrease in diuresis and natriuresis induced by inhibition of NO synthesis. Am J Physiol (1993) 0.81
Haemophilus paraphrophilus endocarditis: case report and review. Clin Infect Dis (1995) 0.81
Treatment of hypertension in the very old. Int J Clin Pract Suppl (2000) 0.81
Tobramycin nephrotoxicity. A prospective clinical study. Postgrad Med J (1979) 0.80
Blood pressure and renal function: therapeutic implications. J Hypertens (1996) 0.80
Nitric oxide, the kidney, and hypertension. Am J Hypertens (1997) 0.80
Efficacy and safety of valsartan, an angiotensin II receptor antagonist, in hypertension after renal transplantation: a randomized multicenter study. Transplant Proc (2006) 0.80
Aging abolishes the renal response to L-arginine infusion in essential hypertension. Kidney Int Suppl (1996) 0.80
[Computerized interpretation of the electrocardiogram in the diagnosis of left ventricular hypertrophy. The ELECTROPRES project]. Rev Clin Esp (2011) 0.79
Effect of losartan on TGF-beta1 and urinary albumin excretion in patients with type 2 diabetes mellitus and microalbuminuria. Nephrol Dial Transplant (2001) 0.79
Clinical perspectives of drugs inhibiting acid secretion: histamine H2 antagonists. Scand J Gastroenterol Suppl (1986) 0.79
Effects of losartan on blood pressure, metabolic alterations, and vascular reactivity in the fructose-induced hypertensive rat. Hypertension (1995) 0.79
N-acetylcysteine potentiates the antihypertensive effect of angiotensin converting enzyme inhibitors. Am J Hypertens (1995) 0.79
Chronic treatment with losartan ameliorates vascular dysfunction induced by aging in spontaneously hypertensive rats. J Hypertens (1998) 0.79
Primary cerebral lymphoma: the "ghost tumor". J Neurosurg (1984) 0.79
Nitric oxide and prostaglandins in the prolonged effects of losartan and ramipril in hypertension. Hypertension (1995) 0.78
Microalbuminuria. Clin Exp Hypertens (2005) 0.78
Effects of captopril on sympathetic activity, lipid and carbohydrate metabolism in a model of obesity-induced hypertension in dogs. Am J Hypertens (1993) 0.78
Increased left ventricular mass in salt-sensitive hypertensive patients. J Hum Hypertens (1996) 0.78
Calcium antagonists and the kidney. Nephrol Dial Transplant (1990) 0.78
Development of Hodgkin's disease in the course of primary Sjögren's syndrome. Br J Rheumatol (1992) 0.78
Influence of converting enzyme inhibition on glomerular filtration rate and proteinuria. Kidney Int (1990) 0.78
Micro-albuminuria is correlated with left ventricular hypertrophy in male hypertensive patients. J Hypertens Suppl (1991) 0.78
Effect of long-term irbesartan treatment on endothelium-dependent vasodilation in essential hypertensive patients. Br J Biomed Sci (2003) 0.78
Individual thermal profiles as a basis for comfort improvement in space and other environments. Aviat Space Environ Med (2002) 0.78
Treatment of hypertension in diabetes mellitus. Curr Hypertens Rep (2000) 0.78
Effects of cicaprost and fosinopril on the progression of rat diabetic nephropathy. Am J Hypertens (1997) 0.78
Therapeutic implications and new perspectives for essential hypertension and renal damage. Kidney Int Suppl (1998) 0.78
[Absence of an association between the C825T polymorphism of the G-protein beta 3 subunit and salt-sensitivity in essential arterial hypertension]. Nefrologia (2001) 0.78
The protective role of atorvastatin on function, structure and ultrastructure in the aorta of dyslipidemic rabbits. Virchows Arch (2000) 0.78
Abnormal Na+-K+ ATPase kinetics in a subset of essential hypertensive patients. Eur J Clin Invest (1988) 0.78
Long-term diuretic therapy and renal function in essential arterial hypertension. Am J Cardiol (1990) 0.78
Hyperkalemia in patients infected with the human immunodeficiency virus: involvement of a systemic mechanism. Kidney Int (1999) 0.78
Factors involved in the effects of losartan on endothelial dysfunction induced by aging in SHR. Kidney Int Suppl (1998) 0.78
Nodular regenerative hyperplasia of the liver in renal transplantation. Transplant Proc (1987) 0.78